Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Dressman

Showing results (11-20 of 124) with videos related to

Pageof 13
Sort By:
Molecular Pharmaceutics|December 15, 2020
Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Support Waivers of <i>In Vivo</i> Clinical Studies: Current Status, Challenges, and OpportunitiesIoannis Loisios-Konstantinidis, Jennifer Dressman
Drug Development and Industrial Pharmacy|May 18, 2012
Selection of excipient, solvent and packaging to optimize the performance of spray-dried formulations: case example fenofibrateMarc Hugo, Klaus Kunath, Jennifer Dressman
The Journal of Pharmacy and Pharmacology|June 7, 2013
Coupling biorelevant dissolution methods with physiologically based pharmacokinetic modelling to forecast in-vivo performance of solid oral dosage formsKeiichi Otsuka, Yasushi Shono, Jennifer Dressman
The Journal of Pharmacy and Pharmacology|July 27, 2018
Differences in drug quality between South Africa and GermanyAndreas Lehmann, Martin Hofsäss, Jennifer Dressman
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 10, 2019
Dissolution behavior of various drugs in different FaSSIF versionsLukas Klumpp, Mathew Leigh, Jennifer Dressman
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 8, 2017
An in silico approach to determine challenges in the bioavailability of ciprofloxacin, a poorly soluble weak base with borderline solubility and permeability characteristicsSimone Hansmann, Yoshihiro Miyaji, Jennifer Dressman
Journal of Pharmaceutical Sciences|April 18, 2018
A Refined Developability Classification SystemJulian Rosenberger, James Butler, Jennifer Dressman
The Journal of Pharmacy and Pharmacology|June 23, 2005
Site-specific delivery of anti-inflammatory drugs in the gastrointestinal tract: an in-vitro release modelSandra Klein, Jürgen Stein, Jennifer Dressman
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 24, 2013
Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenacAtsushi Kambayashi, Henning Blume, Jennifer Dressman
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 26, 2005
Development of an in vitro/in vivo correlation for lipid formulations of EMD 50733, a poorly soluble, lipophilic drug substanceKaren Schamp, Sven-Alexander Schreder, Jennifer Dressman
Pageof 13

Showing results (11-20 of 124) with videos related to

Sort By:
Pageof 13
Molecular Pharmaceutics|December 15, 2020
Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling to Support Waivers of <i>In Vivo</i> Clinical Studies: Current Status, Challenges, and OpportunitiesIoannis Loisios-Konstantinidis, Jennifer Dressman
Drug Development and Industrial Pharmacy|May 18, 2012
Selection of excipient, solvent and packaging to optimize the performance of spray-dried formulations: case example fenofibrateMarc Hugo, Klaus Kunath, Jennifer Dressman
The Journal of Pharmacy and Pharmacology|June 7, 2013
Coupling biorelevant dissolution methods with physiologically based pharmacokinetic modelling to forecast in-vivo performance of solid oral dosage formsKeiichi Otsuka, Yasushi Shono, Jennifer Dressman
The Journal of Pharmacy and Pharmacology|July 27, 2018
Differences in drug quality between South Africa and GermanyAndreas Lehmann, Martin Hofsäss, Jennifer Dressman
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 10, 2019
Dissolution behavior of various drugs in different FaSSIF versionsLukas Klumpp, Mathew Leigh, Jennifer Dressman
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 8, 2017
An in silico approach to determine challenges in the bioavailability of ciprofloxacin, a poorly soluble weak base with borderline solubility and permeability characteristicsSimone Hansmann, Yoshihiro Miyaji, Jennifer Dressman
Journal of Pharmaceutical Sciences|April 18, 2018
A Refined Developability Classification SystemJulian Rosenberger, James Butler, Jennifer Dressman
The Journal of Pharmacy and Pharmacology|June 23, 2005
Site-specific delivery of anti-inflammatory drugs in the gastrointestinal tract: an in-vitro release modelSandra Klein, Jürgen Stein, Jennifer Dressman
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 24, 2013
Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenacAtsushi Kambayashi, Henning Blume, Jennifer Dressman
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 26, 2005
Development of an in vitro/in vivo correlation for lipid formulations of EMD 50733, a poorly soluble, lipophilic drug substanceKaren Schamp, Sven-Alexander Schreder, Jennifer Dressman
Pageof 13